论文部分内容阅读
本文报道１１６例难以手术切除的原发性巨块型肝癌经动脉栓塞术（ＨＡＥ）后，１７例获得二步切除，占１４．６６％。术后一、二、三年生存率分别为６４．７０％、５８．８２％及５２．９４％。作者对ＨＡＥ的意义、碘油混合抗癌药物ＨＡＥ的优点进行了深入讨论，从临床实践及病理学检查说明ＨＡＥ不能代替二步肝切除术。当肿瘤缩小，病变转为可以切除时，应不失时机地进行二步肝切除术。并提出了ＨＡＥ后二步肝切除术的适应症。
This article reported 116 cases of difficult to surgical removal of primary massive liver cancer after transarterial embolization (HAE), 17 patients obtained two-step resection, accounting for 14.66%. The first, second and third year survival rates were 64.70%, 58.82% and 52.94%, respectively. The author discussed the significance of HAE and the advantages of HAE mixed anticancer drug HAE. HAE cannot be used as a substitute for two-step hepatectomy in clinical practice and pathological examination. When the tumor shrinks and the lesion becomes resectable, a two-step hepatectomy should be performed without losing the opportunity. The indications for HAE’s second step hepatectomy were presented.